The DEA laboratory registration extension granted under the 2023 omnibus hemp provisions expires on December 31, 2026. For hemp ingredient suppliers who test through third-party laboratories holding temporary or extended DEA registrations, the clock is running — and for B2B buyers who depend on DEA-registered lab COAs to meet their own compliance obligations, the renewal status of their supplier's testing lab is now a supply chain risk variable worth tracking.
Background: Why DEA Registration Matters for Hemp Testing
Under the federal hemp framework established by the 2018 Farm Bill and reinforced by the Hemp Safety Enforcement Act, hemp ingredient testing must be performed by laboratories holding DEA Schedule I researcher registration. This requirement exists because hemp samples — particularly those approaching or exceeding the 0.3% delta-9 THC threshold — contain a controlled substance under federal law until they are confirmed compliant.
Not every laboratory that performs cannabinoid testing holds DEA registration. Many state-licensed testing labs operate without it, relying on state-level authorization or informal interpretations of federal requirements. Post-November 12, 2026, COAs from non-DEA-registered laboratories will not satisfy federal documentation requirements.
The December 31 Renewal Deadline
The USDA's interim rules and subsequent enforcement guidance extended DEA laboratory registration validity for a class of labs that applied during the initial rollout of the hemp testing framework. Those extensions — which covered laboratories that submitted applications in good faith but experienced DEA processing delays — expire December 31, 2026.
Laboratories whose registrations lapse after this date and have not successfully renewed will be operating outside the framework that the federal hemp compliance standard requires. COAs issued by lapsed-registration labs after December 31 will not carry the evidentiary weight needed to document legal hemp status.
What Suppliers Should Be Doing Now
Hem ingredient suppliers operating in the B2B market should be taking the following steps in Q3 2026:
Verify current registration status. The DEA Diversion Control Division maintains a public database of registered practitioners and researchers. Suppliers should confirm their testing laboratory's current registration number, registration type, and expiration date. This information should also appear on any COA the lab issues.
Confirm renewal submission. DEA registration renewals must be submitted 60 days before expiration to avoid lapsing. For a December 31 deadline, that means submissions should be filed by November 1, 2026 at the latest — which is itself just weeks after the federal hemp compliance deadline. Suppliers should ask their lab partners directly: has renewal been submitted?
Maintain backup testing relationships. Suppliers who rely on a single laboratory should identify at least one alternate DEA-registered, ISO 17025-accredited testing partner. If the primary lab's registration lapses during the renewal process, the supplier needs a path to compliant testing that doesn't require a months-long search for a new lab.
Update supplier documentation packages. Any supplier documentation package sent to B2B customers should include the testing laboratory's current DEA registration number and expiration date. Customers are increasingly asking for this information, and proactively including it reduces friction in the buyer's compliance review.
What B2B Buyers Should Be Asking
Ingredient buyers cannot assume that their current hemp supplier's testing laboratory will remain DEA-registered through and beyond December 31. This is a reasonable due diligence question to add to supplier review processes now:
- What is the DEA registration number of your testing laboratory?
- What is the current expiration date of that registration?
- Has the laboratory submitted its renewal application?
- Do you have a backup testing laboratory relationship if the primary lab's registration lapses?
For brands that have executed supplier quality agreements, the SQA may already require the supplier to notify the buyer of any change in the testing laboratory's regulatory status. If your SQA doesn't include this provision, it's worth adding at next renewal.
ISO 17025 Accreditation Is a Separate Requirement
It's worth noting that DEA registration and ISO 17025 accreditation are independent credentials. A laboratory can hold one without the other. Federal hemp compliance requires both: DEA registration to legally handle samples containing THC, and ISO 17025 accreditation to demonstrate analytical competency.
Buyers should verify both credentials separately. The ISO 17025 accreditation body (typically A2LA or ANAB in the United States) maintains public accreditation databases that can be searched by laboratory name.
The Compounding Risk of Two Deadlines in One Quarter
The unusual situation facing the hemp supply chain in Q4 2026 is that two major compliance deadlines fall within seven weeks of each other: the November 12 federal compliance deadline for THC limits and testing documentation, and the December 31 DEA lab registration renewal deadline.
For suppliers who are simultaneously managing customer documentation requests triggered by November 12 and monitoring their lab partner's DEA renewal status, Q4 2026 will be operationally demanding. The brands that will navigate this smoothly are the ones who began these conversations with their suppliers now.
Conclusion
DEA laboratory registration renewal is not an abstract regulatory technicality — it directly determines whether your hemp ingredient COAs are federally valid. With December 31 approaching and the November 12 compliance framework already live, confirming your supplier's testing lab registration status is a concrete, verifiable step that belongs in every B2B hemp ingredient procurement review this quarter.
Low Gravity Hemp tests all ingredients through DEA-registered, ISO 17025-accredited laboratories. Our COAs include laboratory registration numbers and accreditation documentation as standard. Contact us to review our current documentation package.